Bioline Rx reported $2.61B in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
Arca Biopharma USD 48.72M 338K Dec/2025
Bio Path USD 9.24M 934K Sep/2025
Bioline Rx USD 2.61B 53.2M Sep/2025
Capricor Therapeutics USD 57.37M 11.65M Dec/2025